@ExtraPace agree with all you say including CEO appointed to sell the company , our Chair Condella 30 years of experience in senior executive roles in global pharmaceutical industry , Strategic Adviser Pharma Companies and investors , praised by business leaders with comments such as " Frank is a brilliant strategist and a compelling leader etc etc ." Convinced Condella behind everything gone wrong for us from day one Teva , rewards for getting that financial disaster( for us) over the line would have been eye watering then came our mad one sided lease agreement our gane changing product Nextstellis , millions of dollars of (our money) spent establishing getting it off the groung now showing signs of satisfactory growth we sell the company along with this insanely overvalued product . US hugely populated ( unlike Aust. ) likely do well at long last not us been tossed overboard for our new owners to capitalize on . Strategic strategy ( achieve long term goals) got Condella written all over it right up his ally . What pisses me off we paid management to shaft us the irony shareholders invested millions buying / establishing products we will never benefit from .
MYX Price at posting:
$7.20 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)